[1]许淑萍.米索前列醇对宫内节育器取出术绝经期女性软化宫颈的效果[J].医学信息,2021,34(24):144-146.[doi:10.3969/j.issn.1006-1959.2021.24.037]
　XU Shu-ping.Effect of Misoprostol on Cervical Softening in Intrauterine Device Removal Surgery in Postmenopausal Women[J].Medical Information,2021,34(24):144-146.[doi:10.3969/j.issn.1006-1959.2021.24.037]
点击复制

米索前列醇对宫内节育器取出术绝经期女性软化宫颈的效果()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年24期
页码:
144-146
栏目:
药物与临床
出版日期:
2021-12-15

文章信息/Info

Title:
Effect of Misoprostol on Cervical Softening in Intrauterine Device Removal Surgery in Postmenopausal Women
文章编号:
1006-1959（2021）24-0144-03
作者:
许淑萍
（江西省抚州市宜黄县疾病预防控制中心艾滋病防治科，江西 宜黄 344400）
Author(s):
XU Shu-ping
(AIDS Prevention and Treatment Division,Yihuang County Center for Disease Control and Prevention,Yihuang 344400,Jiangxi,China)
关键词:
米索前列醇; 宫内节育器; 绝经期; 宫颈软化有效率
Keywords:
Misoprostol; Intrauterine device; Menopause; The effective rate of cervical softening
分类号:
R713.9
DOI:
10.3969/j.issn.1006-1959.2021.24.037
文献标志码:
A
摘要:
目的 观察米索前列醇对宫内节育器取出术绝经期女性软化宫颈的效果。方法 选取2019年4月-2020年12月在我中心行宫内节育器取出术的绝经期女性62例，随机分为对照组和观察组，每组31例。对照组术前口服戊酸雌二醇，观察组术前阴道放入米索前列醇。比较两组手术成功率、临床手术指标、疼痛评分、宫颈软化有效率以及不良反应发生情况。结果 观察组手术成功率高于对照组的（96.77% vs 83.87%），差异有统计学意义（P＜0.05）；观察组手术时间、术中出血量均小于对照组，差异有统计学意义（P＜0.05）；观察组疼痛评分小于对照组，差异有统计学意义（P＜0.05）；观察组宫颈软化有效率高于对照组（100.00% vs 80.65%），差异有统计学意义（P＜0.05）；观察组不良反应发生率低于对照组（0 vs 12.90%），差异有统计学意义（P＜0.05）。结论 绝经期女性宫内节育器取出术前给予米索前列醇，可提高手术成功率，减轻疼痛评分，提高宫颈软化有效率，缩短手术时间，减少术中出血量，减轻患者的痛苦，同时阴道给药途径可降低临床不良反应，提高用药安全性，值得临床加以应用。
Abstract:
Objective To observe the effect of misoprostol on cervical softening in intrauterine device removal surgery in postmenopausal women.Methods A total of 62 postmenopausal women who underwent intrauterine device removal surgery in our center from April 2019 to December 2020 were selected and randomly divided into control group and observation group, with 31 cases in each group. The control group was given estradiol valerate orally before operation, and the observation group was given misoprostol in vagina before operation. The operation success rate, clinical operation index, pain score, cervical softening efficiency and adverse reactions were compared between the two groups.Results The success rate of operation in the observation group was higher than that in the control group (96.77% vs 83.87%), and the difference was statistically significant (P<0.05). The operation time and intraoperative blood loss in the observation group were less than those in the control group, and the difference was statistically significant (P<0.05). The pain score of the observation group was lower than that of the control group, and the difference was statistically significant (P<0.05). The effective rate of cervical softening in the observation group was higher than that in the control group (100.00% vs 80.65%), and the difference was statistically significant (P<0.05). The incidence of adverse reactions in the observation group was lower than that in the control group (0 vs 12.90%), and the difference was statistically significant (P<0.05).Conclusion Misoprostol given to postmenopausal women before intrauterine device removal surgery can improve the success rate of surgery, reduce pain score, improve the effective rate of cervical softening, and shorten the operation time, reduce intraoperative bleeding and relieve the pain of patients. At the same time, vaginal administration can reduce clinical adverse reactions and improve the safety of medication, which is worth clinical application.

参考文献/References:

[1]高梅红.不同宫颈准备方法用于绝经后取宫内节育器术的临床效果对比分析[J].中国医药指南,2016,14(24):111.[2]吴兰兰,汪期明,裘亚娟.绝经后女性宫内节育器取出困难的相关影响因素分析[J].现代实用医学,2019,31(5):689-691.[3]赵新,裴开颜,李来宝,等.绝经后IUD取出术的临床观察[J].中国计划生育学杂志,2019,27(10):1288-1293.[4]涂琴.宫内节育器嵌顿的相关影响因素[J].中国当代医药,2019,26(7):149-151.[5]中华医学会计划生育学分会.宫腔操作前宫颈预处理专家共识[J].中华生殖与避孕杂志,2020,40(1):3-8.[6]周文娟.米索前列醇在妇产科中的临床应用[J].实用妇科内分泌杂志,2016,3(4):141-142.[7]曹任敏.米索前列醇不同给药途径用于绝经后妇女取器的临床效果观察[J].中国计划生育学杂志,2019,27(7):949-951.[8]中华医学会计划生育学分会.绝经后宫内节育器取出术指南[J].中华妇产科杂志,2019,54(10):649-653.[9]侯纪湘,李晓燕.坤泰胶囊联合尼尔雌醇治疗更年期综合征的疗效观察[J].现代药物与临床,2017,32(3):488-491.[10]戴翔,曹建国.戊酸雌二醇联合米非司酮在妊娠中期引产中的应用[J].中国现代医生,2016,54(5):58-59,62.[11]俞颂梅,戴洁,陆琴芬,等.可视超声监护仪在绝经后子宫取环中的应用效果观察[J].现代诊断与治疗,2017,28(13):2366-2368.[12]刘洪芳.不同宫颈准备方法在绝经后宫内节育器取出术中的效果比较[J].中外女性健康研究,2017(2):3-4.[13]Zhuo Z,Yu H,Jiang X.A systematic review and meta-analysis of randomized controlled trials on the effectiveness of cervical ripening with Misoprostol administration before hysteroscopy[J].Int J Gynaecol Obstet,2016,132(3):272-277.[14]郭雁青,刘双萍,刘芬.不同软化宫颈药物用于绝经后宫内节育取出术119例疗效分析[J].山西职工医学院学报,2017,27(2):53-55.[15]姜泽允.戊酸雌二醇联合米索前列醇用于绝经期取环对手术时间、疼痛程度和取环成功率的影响[J].河北医药,2016,38(5):729-731.[16]刘伏香,龙丹,周艳.米索前列醇联合雌激素乳膏在绝经后宫内节育器取出术效果[J].中国计划生育学杂志,2020,28(11):1764-1766.[17]贾敬齐.影响围绝经期及绝经期妇女取环难度的相关因素及有效方法[J].中外女性健康研究,2017(19):78.[18]高锦飞.阴道后穹隆放置米索前列醇用于绝经后妇女宫内节育器取出术效果分析[J].实用妇科内分泌电子杂志,2019,33(6):31-32.[19]金美玉,李良昌.两种宫颈预处理在绝经后老年女性宫内节育器取出术中的应用效果[J].中国老年学杂志,2020,40(11):4609-4611.[20]祁英.术前联合应用尼尔雌醇与米索前列醇对绝经期妇女宫内节育器取出术的影响[J].河南医学研究,2018,27(17):3149-3150.

相似文献/References:

[1]周 鑫,王 明,魏 宏.药物流产终止乙肝病毒感染患者10~14周妊娠的 安全性及有效性分析[J].医学信息,2018,31(12):112.[doi:10.3969/j.issn.1006-1959.2018.12.035]
　ZHOU Xin,WANG Ming,WEI Hong.Analysis of Safety and Effectiveness of Stopping Hepatitis B Virus Infection in 10 to 14 Weeks of Pregnancy by Drug Abortion[J].Medical Information,2018,31(24):112.[doi:10.3969/j.issn.1006-1959.2018.12.035]
[2]陈晓娟,卢芳芳,周芳英.丙泊酚、枸橼酸舒芬太尼联合米索前列醇用于无痛人流术的效果[J].医学信息,2019,32(23):154.[doi:10.3969/j.issn.1006-1959.2019.23.048]
　CHEN Xiao-juan,LU Fang-fang,ZHOU Fang-ying.Effect of Propofol,Sufentanil citrate and Misoprostol on Painless Abortion[J].Medical Information,2019,32(24):154.[doi:10.3969/j.issn.1006-1959.2019.23.048]
[3]张 勇.阴道放置米索前列醇在终止6~10周妊娠负压吸宫术前的应用[J].医学信息,2019,32(24):143.[doi:10.3969/j.issn.1006-1959.2019.24.051]
　ZHANG Yong.Application of Vaginal Misoprostol Before Termination of Negative Pressure Uterine Aspiration with 6 to 10 Weeks[J].Medical Information,2019,32(24):143.[doi:10.3969/j.issn.1006-1959.2019.24.051]
[4]王 敏.宫颈扩张球囊与米索前列醇在足月妊娠初产妇促宫颈成熟引产中的效果比较[J].医学信息,2021,34(22):94.[doi:10.3969/j.issn.1006-1959.2021.22.028]
　WANG Min.Comparison of Cervical Dilation Balloon and Misoprostol in Promoting Cervical Ripening and Induction of Labor in Primiparae with Full-term Pregnancy[J].Medical Information,2021,34(24):94.[doi:10.3969/j.issn.1006-1959.2021.22.028]
[5]张志巧.宫颈扩张球囊与米索前列醇在足月妊娠初产妇促宫颈成熟引产中的临床疗效及安全性[J].医学信息,2021,34(24):99.[doi:10.3969/j.issn.1006-1959.2021.24.023]
　ZHANG Zhi-qiao.Clinical Efficacy and Safety of Cervical Dilation Balloon and Misoprostol in Promoting Cervical Ripening and Induction of Labor in Primiparae with Full-term Pregnancy[J].Medical Information,2021,34(24):99.[doi:10.3969/j.issn.1006-1959.2021.24.023]
[6]李晓君.麦角新碱联合米索前列醇、缩宫素在胎盘早剥产后大出血的临床效果及对应激反应的影响[J].医学信息,2023,36(19):141.[doi:10.3969/j.issn.1006-1959.2023.19.031]
　LI Xiao-jun.Clinical Effect of Ergometrine Combined with Misoprostol and Oxytocin in Postpartum Hemorrhage of Placental Abruption and its Effect on Stress Response[J].Medical Information,2023,36(24):141.[doi:10.3969/j.issn.1006-1959.2023.19.031]
[7]张迎春.间苯三酚与米索前列醇对宫腔镜术前宫颈扩张效果及不良反应的影响[J].医学信息,2024,37(15):87.[doi:10.3969/j.issn.1006-1959.2024.15.019]
　ZHANG Ying-chun.Effect of Phloroglucinol and Misoprostol on Cervical Dilatation and Adverse Reactions Before Hysteroscopy[J].Medical Information,2024,37(24):87.[doi:10.3969/j.issn.1006-1959.2024.15.019]

更新日期/Last Update: 1900-01-01